Author

Barbara Sitek

University Hospitals of the Ruhr-University of BochumORCID 0009-0002-1658-7953Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Barbara Sitek1 paper · Jagiellonian University

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

Thilo BrachtiD· 2 shared Antonia Belter· 1 shared Benjamin Katschinski· 1 shared Corinna SchuleriD· 1 shared Fabienne MaaßeniD· 1 shared Katharina Fleischhauer· 1 shared Lars KaderaliiD· 1 shared Lori Frappier· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Thilo BrachtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintAug 26, 2026

Quantitative modeling of SARS-CoV-2 replication reveals phase-specific bottlenecks and antiviral targets

Simon T. Herrmann, Timon Kapischke, Saskia Westhoven…·Lars Kaderali

The paper models SARS-CoV-2 replication dynamics in human cells, identifies key bottlenecks, and evaluates antiviral drug effects using mathematical modeling and experimental data.

DOI 10.64898/2026.06.23.733955

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 17, 2023

The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T-cell recognition by targeting CIITA

Fabienne Maaßen, Vu Thuy Khanh Le-Trilling, Luisa Betke…·Mirko Trilling

This study identifies pUS28 as a viral protein that inhibits CIITA-driven HLA-II expression, thereby blocking CD4+ T-cell recognition of HCMV-infected cells.

DOI 10.1101/2023.10.17.562683

humanproteomics

𝕏 PostBluesky